We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$378M
AUM Growth
-$23.3M
Cap. Flow
-$28M
Cap. Flow %
-7.41%
Top 10 Hldgs %
51.76%
Holding
55
New
2
Increased
11
Reduced
25
Closed
3

Top Buys

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$2.59M
2
LRCX icon
Lam Research
LRCX
+$2.5M
3
HL icon
Hecla Mining
HL
+$284K
4
G icon
Genpact
G
+$155K
5
AOS icon
A.O. Smith
AOS
+$58.2K

Top Sells

Rank Stock Value
1
GNTX icon
Gentex
GNTX
+$4.92M
2
TFC icon
Truist Financial
TFC
+$4.75M
3
UNH icon
UnitedHealth
UNH
+$3.46M
4
WTW icon
Willis Towers Watson
WTW
+$3.16M
5
ULTA icon
Ulta Beauty
ULTA
+$3.07M

Sector Composition

Rank Sector Weight
1 Technology 31.17%
2 Healthcare 14.32%
3 Financials 14.08%
4 Consumer Staples 11.19%
5 Consumer Discretionary 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
26
Visa
V
$684B
$5.3M 1.4%
16,758
-22
-0.1% -$6.62K
OTIS icon
27
Otis Worldwide
OTIS
$27.4B
$5.19M 1.38%
56,094
+156
+0.3% +$15.6K
WTW icon
28
Willis Towers Watson
WTW
$31.2B
$4.95M 1.31%
15,788
-10,291
-39% -$3.16M
G icon
29
Genpact
G
$5.96B
$4.55M 1.2%
105,910
+3,679
+4% +$155K
EXPE icon
30
Expedia Group
EXPE
$35.4B
$4.12M 1.09%
22,135
+74
+0.3% +$12.8K
AOS icon
31
A.O. Smith
AOS
$8.17B
$4.06M 1.08%
59,511
+768
+1% +$58.2K
CDW icon
32
CDW
CDW
$18.9B
$3.86M 1.02%
22,162
-205
-0.9% -$39.8K
CME icon
33
CME Group
CME
$96.3B
$3.51M 0.93%
15,093
+15
+0.1% +$3.45K
WEX icon
34
WEX
WEX
$6.37B
$3.45M 0.91%
19,657
+137
+0.7% +$25.7K
LHX icon
35
L3Harris
LHX
$51.6B
$3.04M 0.8%
14,439
-10,370
-42% -$2.49M
CSCO icon
36
Cisco
CSCO
$457B
$2.48M 0.66%
41,844
– –
LRCX icon
37
Lam Research
LRCX
$367B
$2.38M 0.63%
+32,971
New +$2.5M
UNP icon
38
Union Pacific
UNP
$174B
$2.27M 0.6%
9,951
+35
+0.4% +$8.29K
ABBV icon
39
AbbVie
ABBV
$443B
$2.17M 0.57%
12,200
– –
SONY icon
40
Sony
SONY
$137B
$1.91M 0.51%
90,289
-446
-0.5% -$8.69K
RTX icon
41
RTX Corp
RTX
$290B
$1.72M 0.46%
14,869
– –
ABT icon
42
Abbott
ABT
$183B
$1.38M 0.37%
12,200
– –
KVUE icon
43
Kenvue
KVUE
$36.9B
$1.34M 0.35%
62,724
-107,481
-63% -$2.44M
NVS icon
44
Novartis
NVS
$297B
$1.07M 0.28%
10,984
+133
+1% +$14.2K
PG icon
45
Procter & Gamble
PG
$336B
$592K 0.16%
3,532
– –
KHC icon
46
Kraft Heinz
KHC
$30.7B
$566K 0.15%
18,418
– –
IMXI icon
47
International Money Express
IMXI
$357M
$454K 0.12%
21,798
– –
XOM icon
48
ExxonMobil
XOM
$644B
$342K 0.09%
3,183
– –
SNY icon
49
Sanofi
SNY
$103B
$291K 0.08%
6,036
+252
+4% +$12.8K
HL icon
50
Hecla Mining
HL
$9.47B
$234K 0.06%
+47,600
New +$284K
1
2
3

Similar funds

HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
PAMS
Pinpoint Asset Management (Singapore) Singapore $433M AUM 32.19% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $432M AUM 23% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Foyston, Gordon, & Payne's Q4 2024 Portfolio in Review

As of Q4 2024, Foyston, Gordon, & Payne held 55 positions worth $378M, down 5.8% from $401M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $28M in Q4 2024, closing 3 positions and reducing 25 holdings. Its most notable exit was Gentex, an estimated $4.92M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Lam Research worth $2.38M.

  • Foyston, Gordon, & Payne's largest Q4 2024 buy was Lam Research: 32,971 shares worth $2.38M.
  • Foyston, Gordon, & Payne added most to Icon in Q4 2024, an estimated $2.59M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $3.46M.
  • Foyston, Gordon, & Payne fully exited Gentex in Q4 2024, selling an estimated $4.92M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 52% of its $378M portfolio in Q4 2024.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 3 in Q4 2024.
  • Foyston, Gordon, & Payne's portfolio value fell 5.8% quarter-over-quarter to $378M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2024, filed 14 Feb 2025.